UnknownNot Applicable

Natural Orifice Transluminal Endoscopic Surgery for Colorectal Cancer

Egypt30 participantsStarted 2015-12

Plain-language summary

The purpose of this study is to assess different hybrid natural orifice transluminal endoscopic surgery techniques in management of colorectal cancer as regard: feasibility of the technique, short term oncologic outcome and functional outcome.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Medically fit patient.
. Non metastatic pathologically proven sigmoid colon cancer.
. Non metastatic pathologically proven rectal cancer.
. Patient continent for stool.

Exclusion criteria

. Patients with American Society of Anesthesiologist (ASA) score 4 and 5.
. Patients with cardiac or chest problems that cannot withstand insufflation.
. Unresectable tumors (defined as those who cannot be resected without a high likelihood of leaving microscopic or gross residual disease at the local site because of tumor adherence or fixation).
. Obstructed or perforated cancer.
. Patients with metastatic colorectal cancer.
. Incontinent patients.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Feasibility

Timeframe: 24 hour

operative time

Timeframe: 24 hour

Operative blood loss

Timeframe: 24 hour

Wound complications

Timeframe: two week

Major intraoperative complications

Timeframe: 24 hour

Major postoperative complications

Timeframe: two weeks

Trial details

NCT IDNCT02549456

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12

Contact for this trial

Islam H Metwally, M.Sc

01002985865 dr.islamo@hotmail.com

View on ClinicalTrials.gov More Colorectal Cancer trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Medically fit patient.
. Non metastatic pathologically proven sigmoid colon cancer.
. Non metastatic pathologically proven rectal cancer.
. Patient continent for stool.

Exclusion criteria

. Patients with American Society of Anesthesiologist (ASA) score 4 and 5.
. Patients with cardiac or chest problems that cannot withstand insufflation.
. Unresectable tumors (defined as those who cannot be resected without a high likelihood of leaving microscopic or gross residual disease at the local site because of tumor adherence or fixation).
. Obstructed or perforated cancer.
. Patients with metastatic colorectal cancer.
. Incontinent patients.